Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Claritas Pharmaceuticals, Inc. (V.CLA) had Return on Equity of 273.90% for the most recently reported fiscal year, ending 2017-12-31.
| Income Statement Financials | |
-- |
|
-41.35M |
|
-- |
|
-- |
|
-- |
|
-6.38M |
|
-- |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-41.35M |
|
-6.38M |
|
-5.93M |
|
6.21M |
|
6.21M |
|
-6.80 |
|
-6.80 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
84.71M |
|
-- |
|
-- |
|
-- |
|
99.80M |
|
-15.10M |
|
-94.87M |
|
-15.10M |
|
6.52M |
|
| Cash Flow Statement Financials | |
-7.22M |
|
-12.98M |
|
24.10M |
|
0.87M |
|
4.78M |
|
3.91M |
|
11.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
2.34 |
|
-1.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
273.90% |
43.58% |
|
-48.81% |
|
-367.30% |
|
-2.32 |
|
-1.16 |
|
-1.16 |
|